- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06320054
Preventing Obstetric Complications With Dietary Intervention (PLATE)
Preventing Common Obstetric Complications Through an Immersive, Medically Tailored Meal Program
The goal of this study is to learn whether access to healthy and fresh food, health coaching, and nutrition support intervention can reduce adverse birth outcomes in pregnant women. The main questions it aims to answer are:
- Does access to healthy and fresh food, health coaching and nutrition support reduce the risk of gestational diabetes or preeclampsia and ultimately improve health outcomes for mothers and their newborns?
- Are participants able to successfully utilize the health program? Are participants satisfied and self-equipped to apply the teachings of the program within their lives following their participation in the study? Participants will be randomly assigned to one of two groups.
Participants in the standard of care will be asked to:
- Complete surveys
- Biometric screenings
Participants in the intervention group will be asked to:
- Complete surveys
- Biometric screenings
- Participate in weekly personal health coaching
- Receive and consume provided weekly meals.
Researchers will compare the standard of care to those who receive the intervention to see the impact of the intervention on clinical outcomes including: gestational weight gain, blood pressure, diagnosis of gestational diabetes, diagnosis of gestational hypertension or preeclampsia, and gestational age at birth.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna Palatnik, MD
- Phone Number: 414-805-6624
- Email: apalatnik@mcw.edu
Study Contact Backup
- Name: Amandla Stanley, MSN
- Phone Number: 414-805-6691
- Email: akstanley@mcw.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion criteria:
- Age at enrollment ≥ 18 years of age
- Receiving prenatal care at Froedtert
- ≤ 16 weeks and 6 days of gestation
- At risk of preeclampsia, defined as being eligible for low dose aspirin treatment AND/OR at risk for gestational diabetes defined as having a history of gestational diabetes, OR previously given birth to an infant weighing ≥ 4000 g, OR has a diagnosis of PCOS
- Pre-pregnancy Body Mass Index ≥ 25 kg/m^2
- Resides in Milwaukee County at time of consent
- Low socio-economic status (<200% of FPL defined as receiving Medicaid)
- Able to read and communicate in English
- Has access to a smart device/computer with reliable internet connection
- Has access to a working refrigerator
- Viable singleton pregnancy
Exclusion criteria:
- Diagnosed with Type I or Type II Diabetes or Hemoglobin A1C ≥ 6.5%
- Diagnosed with End Stage Renal Disease
- Use of weight-increasing psychotropic agents
- Active inflammatory bowel disease, or history of bowel resection or malabsorptive syndrome, or history of bariatric surgery
- Significant food allergies, preferences or dietary requirements that would interfere with diet adherence
- Multifetal gestation
- Active substance use that would preclude program adherence
- Chronic use of oral corticosteroids
- Unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard Prenatal Care
Standard Prenatal Care, biometric screenings, and surveys (baseline, 4-12 weeks postpartum).
|
|
Experimental: Maternal Health Management Program
Program participants will receive 10 fresh, local meals each week, delivered to their homes, health coaching including cooking and physical activity, biometrics screenings, and educational support to enable sustainable lifestyle change.
|
Program participants will receive 10 fresh, local meals each week, delivered to their homes, health coaching including cooking and physical activity, biometrics screenings, and educational support to enable sustainable lifestyle change.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
gestational weight gain (BMI early pregnancy in comparison to BMI at delivery)
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
blood pressure (Compared to early pregnancy, intrapartum, postpartum
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Diagnosis of gestational diabetes
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Diagnosis of preeclampsia or gestational hypertension
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Gestational age at birth (Weeks and Days)
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
program utilization (measured by percentage of weekly coaching attended and number of meals consumed)
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
participant satisfaction and retention (measured by end of study evaluation)
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
self-efficacy skills with meals preparation (as measured by nutrition survey)
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
physical activity planning (as measured by physical activity survey)
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Self-Efficacy (as measure by Self-Efficacy survey)
|
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anna Palatnik, MD, Medical College of Wisconsin
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Glucose Metabolism Disorders
- Metabolic Diseases
- Endocrine System Diseases
- Diabetes Mellitus
- Pregnancy Complications
- Hypertension
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Pre-Eclampsia
- Diabetes, Gestational
- Hypertension, Pregnancy-Induced
Other Study ID Numbers
- PRO00049771
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preeclampsia
-
MemorialCare Health SystemNot yet recruitingPreeclampsia | Preeclampsia Postpartum | Preeclampsia Severe | Preeclampsia Mild
-
Christiana Care Health ServicesActive, not recruitingPre-Eclampsia | Preeclampsia | Preterm | Preeclampsia Severe | Preeclampsia Second Trimester | Preeclampsia Complicating Childbirth | Preeclampsia PuerperiumUnited States
-
University Medical Centre LjubljanaCompletedPreeclampsia Postpartum | Preeclampsia SevereSlovenia
-
Cedars-Sinai Medical CenterThermoFisher Scientific Brahms Biomarkers FranceCompletedGestational Hypertension | Preeclampsia Severe | Preeclampsia and Eclampsia | Chronic Hypertension in Obstetric Context | Superimposed Pre-Eclampsia | Preeclampsia MildUnited States
-
Washington University School of MedicineRecruitingPreeclampsia Postpartum | Preeclampsia SevereUnited States
-
Brigham and Women's HospitalCompletedHypertension in Pregnancy | Postpartum | Postpartum Preeclampsia | Gestational Hypertension | Preeclampsia SevereUnited States
-
Christiana Care Health ServicesNot yet recruitingPreterm Birth Complication | Preeclampsia Severe | Preeclampsia Second TrimesterUnited States
-
AMAG Pharmaceuticals, Inc.TerminatedSevere PreeclampsiaUnited States, Poland, South Africa
-
Mpilo Central HospitalCompletedSevere PreeclampsiaZimbabwe
Clinical Trials on Maternal Health Management Program
-
Centro de Estudos em Medicina ComportamentalCompletedPsychological Well Being | Behavioral ManagementBrazil
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompletedChronic DiseaseUnited States
-
Northwestern UniversityCompletedQuality of Life | Stress, Emotional | Cancer-related Problem/ConditionUnited States
-
Hospital Universitario La PazRecruitingChronic Obstructive Pulmonary DiseaseSpain
-
Brigham and Women's HospitalPatient-Centered Outcomes Research InstituteCompleted
-
Jimma UniversityWachemo UniversityRecruitingMaternal HealthEthiopia
-
Johns Hopkins UniversityCompletedChronic Low-back Pain | Patient ActivationUnited States
-
University of Colorado, DenverCompletedDiabetes Complications | Peripheral Arterial DiseaseUnited States
-
Denver Health and Hospital AuthorityUniversity of Colorado, DenverCompleted
-
Kaiser PermanenteCompletedChronic ConditionsUnited States